Company Filing History:
Years Active: 2019-2021
Title: Justus Claus Daechsel: Innovator in Antibody Research
Introduction
Justus Claus Daechsel is a prominent inventor based in Valby, Denmark. He has made significant contributions to the field of antibody research, particularly in the treatment of ocular diseases and neurodegenerative disorders. With a total of 4 patents to his name, Daechsel's work is paving the way for innovative therapeutic solutions.
Latest Patents
Daechsel's latest patents include groundbreaking inventions such as "Antibodies specific for hyperphosphorylated tau for the treatment of ocular diseases." This invention focuses on antibodies that are highly specific for hyperphosphorylated pathogenic P-S396 tau and labelled sections of the human retina. These antibodies are intended for use in treating retinoid amyloidosis, age-related macular degeneration (ARMD), and glaucoma. Another notable patent is "Antibodies specific for hyperphosphorylated tau and methods of use thereof." This invention relates to a class of monoclonal antibodies that specifically bind to the phosphorylated serine 396 residue on pathological hyperphosphorylated tau (pS396) with improved affinity. These antibodies are aimed at treating Alzheimer's disease and other tauopathies.
Career Highlights
Justus Claus Daechsel is currently associated with H. Lundbeck A/S, a leading pharmaceutical company specializing in brain diseases. His work at Lundbeck has allowed him to focus on developing innovative treatments that address critical health challenges.
Collaborations
Throughout his career, Daechsel has collaborated with esteemed colleagues such as Jan Torleif Pedersen and Lars Østergaard Pedersen. These collaborations have further enhanced the impact of his research and inventions.
Conclusion
Justus Claus Daechsel is a notable inventor whose work in antibody research is making significant strides in the treatment of various diseases. His innovative patents and collaborations reflect his commitment to advancing medical science and improving patient outcomes.